Lexicon Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Lexicon Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Lexicon Pharmaceuticals Inc Strategy Report
- Understand Lexicon Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Lexicon Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 28 Jul 2022 | Lexicon Pharma Completes Full Exercise of Over-Allotment Option of Private Placement of Shares for USD49.3 Million | Private Equity |
Invus LP
|
Lexicon Pharmaceuticals Inc |
| 27 Jul 2022 | Lexicon Pharma Completes Full Exercise of Underwriters Over-Allotment Option of Public Offering of Shares for USD48.4 Million | Equity Offering | - |
Lexicon Pharmaceuticals Inc |
| 06 Aug 2021 | Lexicon Pharma Files Registered Statement for Public Offering of Securities for Up to USD200 Million | Equity Offering | - |
Lexicon Pharmaceuticals Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer